论文部分内容阅读
异名 Digibind,Ovine 成分地高辛特异抗体分段药效分类急救解毒药开发单位 (美)Burroughs Wellcom 上市厂商 (美)Burroughs Wellcom1986年首次上市药理本品是免疫抗体首次批准作为药物的生物制品。用地高辛与人体白蛋白的结合物使羊免疫的方法制得,若使本品再分裂、离析为碎片,就需要与地高辛结合。由于本品的分子碎片较小,易广泛分布到体内,迅速与地高辛结合。此结合物对地高辛分子有高度亲和力,可使地高辛分子失去对人体细胞作用部位的结合,从而被迅速排出体外。静注本品半小时内显效,能改善地高辛中毒症状。临床与适应症由于本品临床使用有限,重复治疗的结果尚不确切,因此本品应严
Synonyms Digibind, Ovine Component digoxin antibody Subsection Pharmacokinetics First Aid Disinfectants Development Unit (US) Burroughs Wellcom Listed Company (US) Burroughs Wellcom, first consignment of 866 drugs in Mexico in 1986, is the first of its kind approved by the Commission. The combination of digoxin and human albumin immunization of sheep made, if the product re-division, segregation of debris, you need to combine with digoxin. Due to the small molecular fragments of this product, easy to widely distributed to the body, quickly combined with digoxin. This conjugate has a high affinity for digoxin molecules, allowing digoxin molecules to lose their binding sites on human cells and thus excreting rapidly. Intravenous injection of the product within half an hour markedly, can improve the symptoms of digoxin. Clinical and indications Because of the limited clinical use of this product, the results of repeated treatment is not clear, so this product should be strict